Harmony Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Buy
+3,330
New +$210K 0.05% 192
2026
Q2
– Sell
-3,390
Closed -$206K – 205
2026
Q1
$206K Buy
+3,390
New +$198K 0.06% 189

Other funds holding BMY

Harmony Asset Management's BMY Position: Q3 2026 in Review

Harmony Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,330 shares worth $208K. The stake represents 0.05% of the portfolio and ranks #192 among its holdings. This is a return to the name: Harmony Asset Management previously reported a position in BMY as recently as Q1 2026.

Harmony Asset Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 1,093 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Harmony Asset Management held 3,330 shares of Bristol-Myers Squibb worth $208K as of Q3 2026.
  • Bristol-Myers Squibb was a new Harmony Asset Management position in Q3 2026.
  • Bristol-Myers Squibb made up 0.05% of Harmony Asset Management's portfolio in Q3 2026, its #192 holding.
  • Harmony Asset Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • 1,093 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Harmony Asset Management's 13F filing for Q3 2026, filed 20 Oct 2026.